Board of Directors

Board of Directors | Cure Arthritis
Debbie Sampson

Debbie Sampson

Treasurer, ANRF Board of Directors
Philanthropist and Community Advocate


Why Debbie Sampson is involved in ANRF:


“We all know someone who suffers from some form of arthritis or auto immune disease. It affects millions of people and the hope of a cure is through research. I’m a firm believer in the fact that the young minds are the key to the future success of finding a cure and at ANRF we look for the best research from young scientists to fund. I’m proud to be a part of this.”


Sally Anne Sheridan | Sotheby's

Hon. Sally Anne Sheridan

Secretary, ANRF Board of Directors
Mayor of Irvine – 1990-92, City of Irvine City Council – 1984-92
Sotheby’s HOM Real Estate Group


Sally Anne Sheridan is involved in ANRF:


As a former nurse, Mrs. Sheridan has a special passion for the work of the Arthritis National Research Foundation (ANRF). “By funding young researchers with cutting-edge ideas, ANRF is putting money to work in the most effective way to find a cure for these debilitating joint diseases,” she said.


Kelly Rouba-Boyd | New Jersey

Kelly Rouba-Boyd

Program Officer
State of New Jersey


Why Kelly Rouba-Boyd is involved in ANRF:


“What impresses me most about the Arthritis National Research Foundation is the sincere compassion demonstrated by both staff and Board members. As someone suffering from severe rheumatoid arthritis, it’s comforting to know that I can always turn to them for support. And on those really tough days, it also gives me hope knowing that they are focused on finding better treatments and ultimately a cure.”


Schalon Newton | Trefoil Therapeutics

Schalon Newton, D.M.

Chair, ANRF Board of Directors
Chief Business Officer
Trefoil Therapeutics


Why Schalon Newton is involved in ANRF:


“With family members who have arthritis I am acutely aware of the challenges of this category of diseases and the limitations that exist with currently available therapies. The early research support that ANRF provides for innovative new approaches to the diagnosis and treatment of these autoimmune conditions is a critical need as government funding is under increasing pressure and corporations increasingly prioritize spending on development projects rather than pure research. ANRF is a uniquely focused organization with the single goal of advancing early stage research.”


Zaher Nahle, PhD

Zaher Nahle, PhD, MPA

Chief Executive Officer
Arthritis National Research Foundation


Why Dr. Nahle is involved in ANRF:


“I am very humbled to be the one entrusted by this truly formidable board of directors, working alongside an all-star Scientific Advisory Board, a dedicated group of colleagues, and our wonderful volunteers. This is an incredible opportunity to serve patients through finding solutions for a complex, multifactorial disease. I live with arthritis myself, so I know the challenges firsthand. Going forward, as we remain laser-focused on our mission, I firmly believe that our contributions will continue to be exciting and transformative.”


Kevin Donohue | Morgan Stanley

Kevin Donohue

2nd Vice Chair, ANRF Board of Directors

Vice President
Morgan Stanley


Why Kevin Donohue is involved in ANRF:


“I know that many millions of individuals are affected by arthritis – and that many more will be affected in the future. I’m glad to be part of an organization working to end the suffering of people by funding top research scientists with cutting-edge ideas. Our goal is a cure.”


Jonathan Rose

Capital Group

Douglas A. Granger, PhD.

Vice Chair, ANRF Board of Directors

Director, Chancellor’s Professor
Institute for Interdisciplinary Salivary Bioscience Research (IISBR)
University of California Irvine

Mark Schulten | Wells Fargo Advisors

Mark Schulten

Managing Director – Investments
The Schulten Group of Wells Fargo Advisors


Why Mark Schulten is involved in ANRF:


“It is a pleasure to be part of an organization that has made such important inroads in the field of arthritis research — especially when I see the degenerative impact of arthritis on so many of my family members.”


Carl Ware, PhD | Arthritis Research

Carl F. Ware, Ph.D.

Chairman, Scientific Advisory Board
Director, Infectious and Inflammatory Diseases Center
Professor, Laboratory of Molecular Immunology
SBP Medical Discovery Institute, La Jolla, CA


Why Carl F. Ware, Ph.D. is involved in ANRF:


Possibilities and challenges are what this researcher, who currently has two important discoveries at various stages of the drug development process, seems to be all about. Dr. Ware hopes that his discoveries will help the 30 to 40 percent of rheumatoid arthritis and Crohn’s sufferers who don’t respond well or at all to the existing TNF based therapies …


Craig Walsh, PhD | UC Irvine

Craig Walsh, Ph.D.


Professor, Molecular Biology and Biochemistry
University of California, Irvine School of Biological Sciences
Co-Director, Institute for Immunology
Director, Multiple Sclerosis Research Center


Dr. Walsh is an expert in Immunology and his research focuses on the role apoptotic signal transduction plays in the development, activation and homeostasis of the immune system. His lab’s current interests…


Read more about ANRF Scientific Advisory Board Member Craig Walsh, Ph.D.

Director Emeritus

Gale Morrie Granger, PhD | UC Irvine

Gale A. Granger, Ph.D. (1937-2018)

Professor of Immunology, Retired
University of California, Irvine


Why Gale A. Granger is involved in ANRF:


Early in his career as a researcher at the University of California, Irvine, Dr. Granger received funding from ANRF to study the immunological processes occurring in the tissue destruction observed in Rheumatoid Arthritis. His subsequent findings changed the world’s treatments in many related fields…


Travis A. Montgomery

Retired Vice President and Chief of Staff
The Queen Mary


Why Travis Montgomery is involved in ANRF:


“It’s exciting to see how far the Foundation has grown from funding research grants only in California to funding quality research programs at some of the most prestigious research centers in America.”